×
About 9,313 results

ALLMedicine™ Malignant Melanoma Center

Research & Reviews  3,060 results

T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer
https://clinicaltrials.gov/ct2/show/NCT02133196

Aug 5th, 2022 - Background: Patients with metastatic non-small cell lung cancer (NSCLC) have few approved therapeutic options and those that exist are of transient benefit. Recent clinical experiences with experimental agents that release checkpoints on the host ...

Effect of Tumor Treating Fields (TTFields) (150 kHz) Concurrent With Standard of Care Therapies for Treatment of Stage 4 Non-small Cell Lung Cancer (NSCLC) Following Platinum Failure (LUNAR)
https://clinicaltrials.gov/ct2/show/NCT02973789

Aug 5th, 2022 - PAST PRE-CLINICAL AND CLINICAL EXPERIENCE: The effect of the electric fields (TTFields, TTF) has demonstrated significant activity in in vitro and in vivo NSCLC pre-clinical models both as a single modality treatment and in combination with chemot...

Effect of Tumor Treating Fields (TTFields, 150 kHz) as Front-Line Treatment of Locally-advanced Pancreatic Adenocarcinoma Concomitant With Gemcitabine and Nab-paclitaxel (PANOVA-3)
https://clinicaltrials.gov/ct2/show/NCT03377491

Aug 5th, 2022 - PAST PRE-CLINICAL AND CLINICAL EXPERIENCE: The effect of the electric fields (TTFields, TTF) has demonstrated significant activity in in vitro and in vivo pancreatic adenocarcinoma pre-clinical models both as a single modality treatment and in com...

Dose Escalation Study of WTX-124 as Monotherapy and in Combination With Pembrolizumab (Pembro) in Patients With Selected Advanced or Metastatic Solid Tumors
https://clinicaltrials.gov/ct2/show/NCT05479812

Aug 5th, 2022 - This is a first-in-human, Phase I, open-label, multicenter study designed to evaluate the safety, tolerability and preliminary efficacy of WTX-124, a conditionally-activated IL-2 prodrug, when administered as monotherapy and in combination with pe...

Dermoscopy as response evaluation tool for cutaneous malignant melanoma metastases trea...
https://doi.org/10.1111/jdv.18479
Journal of the European Academy of Dermatology and Venere... Stahlie EHA, van Akkooi ACJ et. al.

Aug 4th, 2022 - Currently, the response of cutaneous melanoma metastases (CMM) to treatment with Talimogene Laherparepvec (T-VEC) is evaluated by clinical examination, macroscopic lesion photography and 3-monthly PET-CT scans. When a complete response (CR) is sus...

see more →

Guidelines  2 results

Japan Society of Gynecologic Oncology guidelines 2015 for the treatment of vulvar cance...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5882649
International Journal of Clinical Oncology; Saito T, Tabata T et. al.

Nov 22nd, 2017 - Vulvar cancer and vaginal cancer are relatively rare tumors, and there had been no established treatment principles or guidelines to treat these rare tumors in Japan. The first version of the Japan Society of Gynecologic Oncology (JSGO) guidelines...

Cutaneous malignant melanoma: ESMO clinical recommendations for diagnosis, treatment an...
https://doi.org/10.1093/annonc/mdn100
Annals of Oncology : Official Journal of the European Soc... Dummer R, Hauschild A et. al.

May 9th, 2008 - Cutaneous malignant melanoma: ESMO clinical recommendations for diagnosis, treatment and follow-up.|2008|Dummer R,Hauschild A,Jost L, ,|diagnosis,epidemiology,pathology,therapy,diagnosis,epidemiology,pathology,therapy,

see more →

Drugs  10 results see all →

Clinicaltrials.gov  333 results

T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer
https://clinicaltrials.gov/ct2/show/NCT02133196

Aug 5th, 2022 - Background: Patients with metastatic non-small cell lung cancer (NSCLC) have few approved therapeutic options and those that exist are of transient benefit. Recent clinical experiences with experimental agents that release checkpoints on the host ...

Effect of Tumor Treating Fields (TTFields) (150 kHz) Concurrent With Standard of Care Therapies for Treatment of Stage 4 Non-small Cell Lung Cancer (NSCLC) Following Platinum Failure (LUNAR)
https://clinicaltrials.gov/ct2/show/NCT02973789

Aug 5th, 2022 - PAST PRE-CLINICAL AND CLINICAL EXPERIENCE: The effect of the electric fields (TTFields, TTF) has demonstrated significant activity in in vitro and in vivo NSCLC pre-clinical models both as a single modality treatment and in combination with chemot...

Effect of Tumor Treating Fields (TTFields, 150 kHz) as Front-Line Treatment of Locally-advanced Pancreatic Adenocarcinoma Concomitant With Gemcitabine and Nab-paclitaxel (PANOVA-3)
https://clinicaltrials.gov/ct2/show/NCT03377491

Aug 5th, 2022 - PAST PRE-CLINICAL AND CLINICAL EXPERIENCE: The effect of the electric fields (TTFields, TTF) has demonstrated significant activity in in vitro and in vivo pancreatic adenocarcinoma pre-clinical models both as a single modality treatment and in com...

Dose Escalation Study of WTX-124 as Monotherapy and in Combination With Pembrolizumab (Pembro) in Patients With Selected Advanced or Metastatic Solid Tumors
https://clinicaltrials.gov/ct2/show/NCT05479812

Aug 5th, 2022 - This is a first-in-human, Phase I, open-label, multicenter study designed to evaluate the safety, tolerability and preliminary efficacy of WTX-124, a conditionally-activated IL-2 prodrug, when administered as monotherapy and in combination with pe...

Evaluation of the Safety and Tolerability of i.v. Administration of a Cancer Vaccine in Patients With Advanced Melanoma
https://clinicaltrials.gov/ct2/show/NCT02410733

Jul 26th, 2022 - The Lipo-MERIT vaccine consists of four naked ribonucleic acid (RNA)-drug products (DPs) that are optimized to induce antigen-specific cluster of differentiation (CD)8+ and CD4+ T cell responses against the four selected malignant melanoma-associa...

see more →

News  320 results

Artificial Intelligence Increasingly Aids Dermatologists
https://www.medscape.com/viewarticle/977396

Jul 18th, 2022 - MADRID — The growing relevance of the use of artificial intelligence in dermatologists' day-to-day work, especially in diagnostic processes, was the focus of one of the sessions held during the 49th National Congress of the Spanish Academy of Derm...

Conjunctival Melanoma of the Left Lower Eyelid
https://www.mdedge.com/dermatology/article/254896/melanoma/conjunctival-melanoma-left-lower-eyelid
William Henry, MD, Shawn Nash, DO et. al.

May 24th, 2022 - To the Editor: A 58-year-old man with a pigmented lesion on the left lower eyelid was referred to the oculoplastic clinic by an outside ophthalmologist. The patient had noticed the lesion growing over the course of the last 4 to 5 months.

Skill Checkup: A 73-Year-Old Woman With Resected Melanoma in the Cervical Spine
https://www.medscape.com/viewarticle/969171

Apr 6th, 2022 - The Skill Checkup series provides a quick, case-style interactive quiz highlighting key guidelines- and evidence-based information to inform clinical practice. A 73-year-old woman presented for follow-up of malignant melanoma. The melanoma was res...

Adverse Skin Effects of Cancer Immunotherapy Reviewed
https://www.medscape.com/viewarticle/970581

Mar 18th, 2022 - Immune checkpoint inhibitors (ICIs) have unquestionably revolutionized the care of patients with malignant melanoma, non-small cell lung cancer, and other types of cancer. But about 40% of patients with cancer treated with ICIs will experience imm...

Why is there an increased risk of cancer in depressed patients?
https://www.mdedge.com/psychiatry/article/252611/major-depressive-disorder/why-there-increased-risk-cancer-depressed
Doug Brunk

Mar 9th, 2022 - LAS VEGAS – Is the relationship between major depressive disorder and the development of cancer, cardiovascular disease, and other medical conditions a coincidence, or is there more at play? According to Charles B. Nemeroff, MD, PhD, a host of cir.

see more →